Investors who hold shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) long should contact the Shareholders Foundation in connection with Lawsuit against Directors

The Shareholders Foundation, Inc. announces that a lawsuit is currently pending by an investor in NASDAQ: REGN shares against certain directors of Regeneron Pharmaceuticals, Inc.

Investors who purchased shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) long-term and continue to hold any of those NASDAQ: REGN shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

In June 2021 an investor in NASDAQ: REGN shares filed a lawsuit against certain directors of Regeneron Pharmaceuticals, Inc. alleging breaches of fiduciary duty. The plaintiff claims that "many of the Individual Defendants, including a majority of the current Board members, collectively sold over $650 million in Regeneron stock (pursuant to the exercise of stock options) during this time" and that the lawsuit "seeks to recover those damages for the benefit of the Company from the true wrongdoers - the officers and directors of Regeneron."

The plaintiff said that the lawsuit arose from the allegedly improper behavior of Regeneron with the allegations originating from another lawsuit against Regeneron from June 2020. Back in June 2020, the United States initiated a lawsuit against Regeneron. The core allegation in that action is that Regeneron allegedly improperly covered Eylea's copay for Medicare beneficiaries through purported charitable donations, which the United States claims violated the federal Anti-Kickback Statute and False Claims Act.

Both cases are currently pending.

Those who purchased shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) should contact the Shareholders Foundation, Inc.

Those who purchased shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.